AI assistant
AVADEL PHARMACEUTICALS PLC — Director's Dealing 2024
Sep 13, 2024
31920_dirs_2024-09-13_c46db2ac-9a2c-49c8-8d93-5ad8bdd522be.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2024-09-13
Reporting Person: Glass Geoffrey Michael (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-13 | Stock Option (Right to Buy) | $16.32 | G | 11000 | Disposed | 2034-07-30 | Ordinary Shares (11000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $16.32 | 2034-07-30 | Ordinary Shares (11000) | 11000 | Indirect |
Footnotes
F1: The options shall vest in full on the earlier to occur of (a) July 30, 2025 or (b) the date of the next annual general meeting of shareholders following the date of grant (July 30, 2024), subject to the Reporting Person's continued service at such time.
F2: On September 13, 2024, the Reporting Person transferred 11,000 options to the Geoffrey M. Glass Revocable Trust u/t/d August 26, 2020, of which the Reporting Person is trustee. The Reporting Person and members of his immediate family are the sole beneficiaries of the trust.